This is a StreetInsider.com Premium Only Page

(PSNL) –

Apr 24, 2024 04:01 PM Personalis to Announce First Quarter 2024 Financial Results

Apr 2, 2024 04:56 PM Form ARS Personalis, Inc. For: Dec 31

Apr 2, 2024 04:53 PM Form DEFA14A Personalis, Inc.

Apr 2, 2024 04:00 PM Form DEF 14A Personalis, Inc. For: May 17

Mar 28, 2024 04:01 PM Personalis to Present at the 23rd Annual Needham Virtual Healthcare Conference

Mar 28, 2024 09:00 AM Data Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Mar 26, 2024 09:00 AM Personalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response Monitoring

Mar 19, 2024 04:43 PM Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mar 19, 2024 04:33 PM Form 4 Personalis, Inc. For: Mar 15 Filed by: Hall Christopher M

Mar 19, 2024 04:32 PM Form 4 Personalis, Inc. For: Mar 15 Filed by: Moore Stephen Michael

Mar 19, 2024 04:32 PM Form 4 Personalis, Inc. For: Mar 15 Filed by: Tachibana Aaron

Mar 19, 2024 04:32 PM Form 4 Personalis, Inc. For: Mar 15 Filed by: Chen Richard

Mar 5, 2024 05:16 PM Form 4 Personalis, Inc. For: Mar 01 Filed by: MYERS WOODROW A JR

Feb 29, 2024 06:21 AM Form S-8 Personalis, Inc.

Feb 29, 2024 05:18 AM Personalis (PSNL) PT Raised to $3.50 at Needham, '4Q23 Consistent with Preannouncement; Aiming for $100M of Sales in 2025'

Feb 28, 2024 05:41 PM Form 10-K Personalis, Inc. For: Dec 31

Feb 28, 2024 04:04 PM Personalis, Inc. (PSNL) Misses Q4 EPS by 4c, provides guidance

Feb 28, 2024 04:01 PM Personalis Reports Fourth Quarter and Full Year 2023 Financial Results

Feb 28, 2024 04:00 PM Form 8-K Personalis, Inc. For: Feb 28

Feb 14, 2024 04:01 PM Personalis to Announce Fourth Quarter and Full Year 2023 Financial Results

Jan 31, 2024 04:30 PM Form 4 Personalis, Inc. For: Jan 29 Filed by: Chen Richard

Jan 31, 2024 04:28 PM Form 4 Personalis, Inc. For: Jan 29 Filed by: Tachibana Aaron

Jan 31, 2024 04:01 PM Personalis to Participate at Upcoming Investor Conferences

Jan 30, 2024 09:00 AM Personalis and ClearNote Health Announce Partnership to Advance Epigenomic Technology

Jan 29, 2024 04:01 PM Form SC 13G/A Personalis, Inc. Filed by: ARK Investment Management LLC

Jan 26, 2024 05:26 PM Form SC 13G/A Personalis, Inc. Filed by: BlackRock Inc.

Jan 17, 2024 04:15 PM Personalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Jan 16, 2024 09:05 AM Personalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling Assay

Jan 10, 2024 06:03 AM Form EFFECT Personalis, Inc.

Jan 9, 2024 06:02 AM Form EFFECT Personalis, Inc.

Jan 5, 2024 09:10 AM Personalis (PSNL) Reports Preliminary Fourth Quarter and Full Year 2023 Revenue and Cash Balance

Jan 5, 2024 09:10 AM Form 8-K Personalis, Inc. For: Jan 05

Jan 5, 2024 09:05 AM Personalis Reports Preliminary Fourth Quarter and Full Year 2023 Revenue and Cash Balance

Dec 21, 2023 05:18 PM Personalis, Inc. (PSNL) Files For 9.22M Share Offering by Selling Stockholders

Dec 21, 2023 05:16 PM Form S-3 Personalis, Inc.

Dec 21, 2023 05:14 PM Personalis, Inc. (PSNL) Files $200M Mixed Shelf

Dec 21, 2023 05:13 PM Form S-3 Personalis, Inc.

Dec 19, 2023 06:09 PM Form 4 Personalis, Inc. For: Dec 15 Filed by: Chen Richard

Dec 19, 2023 06:08 PM Form 4 Personalis, Inc. For: Dec 15 Filed by: Tachibana Aaron

Dec 19, 2023 06:03 PM Form 4 Personalis, Inc. For: Dec 15 Filed by: Moore Stephen Michael

Dec 7, 2023 02:46 PM Form SC 13G/A Personalis, Inc. Filed by: JPMORGAN CHASE & CO

Dec 5, 2023 04:08 PM Form 3 Personalis, Inc. For: Nov 28 Filed by: Tempus Labs, Inc.

Dec 5, 2023 04:06 PM Form SC 13G Personalis, Inc. Filed by: Tempus Labs, Inc.

Dec 5, 2023 06:02 AM Form 8-K Personalis, Inc. For: Nov 30

Dec 4, 2023 09:16 AM Personalis, Inc. (PSNL) discloses reduction in headcount impacting approximately 20%

Dec 4, 2023 09:15 AM Personalis Extends Cash Position Into 2026, Provides Update on Key Initiatives

Dec 1, 2023 04:52 PM Form 8-K Personalis, Inc. For: Dec 01

Nov 28, 2023 04:59 PM Form 8-K Personalis, Inc. For: Nov 25

Nov 28, 2023 04:22 PM Personalis, Inc. (PSNL) and Tempus Enter into a Strategic Collaboration to Advance Cancer Testing

Nov 28, 2023 04:15 PM Personalis and Tempus Enter into a Strategic Collaboration to Advance Cancer Testing